Menten AI Launches MAUD 1.0 Platform

🚀 Platform launch: MAUD 1.0

Today, we’re excited to introduce MAUD 1.0 — the next evolution of our system for AI-driven design of cyclic peptide medicines.

🎥 Watch a short overview of what we do on YouTube.‍

Platform Highlights:
• MAUD 1.0 adds new capability for nM-level potency and high membrane permeability in one design cycle
• Opens the door to drugging challenging targets beyond the reach of small molecules and biologics
• Designed to translate cutting-edge computation into real medicines

At Menten AI, we’re focused on unlocking hard-to-drug targets by designing peptide macrocycles from scratch. MAUD 1.0 combines generative AI, physics-based modeling, and advanced molecular simulations to explore entirely new regions of chemical space — with the goal of creating peptide therapeutics that balance potency, membrane-permeability, selectivity, and favorable DMPK.

🔗 Explore the platform, our science, and our team on the new site: https://www.menten.ai

We’re excited to share what we’ve been building —and what’s coming next. 🎉